Trials / Unknown
UnknownNCT06298981
Pulse Rate and Breathing Rate Accuracy
Pulse Rate and Breathing Rate Accuracy Study - NuraLogix AMC-SDK
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Nuralogix Corporation · Industry
- Sex
- All
- Age
- 18 Years – 81 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to conduct a Breathing Rate and Pulse Rate accuracy validation comparing the NuraLogix AMC-SDK to the Reference devices, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda) and a standard ECG (GE Datex-Ohmeda) derived heart rate reference. This will be done by manually scoring the collected waveform for data analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | noninvasive and investigational NuraLogix AMC-SDK | The NuraLogix AMC-SDK is a noninvasive device that allows for real-time, remote measuring using facial recordings. |
Timeline
- Start date
- 2024-02-12
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2024-03-07
- Last updated
- 2024-03-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06298981. Inclusion in this directory is not an endorsement.